Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2001, p. 2144-2146, Vol. 45, No. 7
Virco UK, Ltd, Cambridge CB4
0GA,1 and Structural Biology Division,
The Wellcome Trust Centre for Human Genetics, University of Oxford,
Oxford OX3 7BN,2 United Kingdom
Received 18 December 2000/Returned for modification 9 March
2001/Accepted 25 April 2001
We have found a close correlation between viral stavudine (d4T)
resistance and resistance to d4T-triphosphate at the human immunodeficiency virus type 1 reverse transcriptase (RT) level. RT from
site-directed mutants with 69S-XX codon insertions and/or conventional
zidovudine resistance mutations seems to be involved in an
ATP-dependent resistance mechanism analogous to pyrophosphorolysis, whereas the mechanism for RT with the Q151M or V75T mutation appears to
be independent of added ATP for reducing binding to d4T-triphosphate.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2144-2146.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Biochemical Mechanism of Human Immunodeficiency
Virus Type 1 Reverse Transcriptase Resistance to Stavudine
*
Corresponding author. Mailing address for Brendan A. Larder: Virco UK, Ltd, 184 Cambridge Sciences Rd., Milton Rd.,
Cambridge CB4 0GA, United Kingdom. Phone: 44 1 223 728 828. Fax: 44 1 223 728 801. E-mail: brendan.larder{at}vircolab.com. Mailing
address for Johan Lennerstrand: Division of Clinical Virology, F68,
Huddinge University Hospital, 141 86 Stockholm, Sweden. Phone: 46 8 58581304. Fax: 46 8 58581305. E-mail:
johan.lennerstrand{at}impi.ki.se.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |